These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18937118)

  • 41. The intranigral injection of tissue plasminogen activator induced blood-brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat.
    Villarán RF; de Pablos RM; Argüelles S; Espinosa-Oliva AM; Tomás-Camardiel M; Herrera AJ; Cano J; Machado A
    Neurotoxicology; 2009 May; 30(3):403-13. PubMed ID: 19442825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anxiety disorders and Parkinson's disease.
    Iruela LM; Ibañez-Rojo V; Palanca I; Caballero L
    Am J Psychiatry; 1992 May; 149(5):719-20. PubMed ID: 1575281
    [No Abstract]   [Full Text] [Related]  

  • 43. An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat.
    Bukhatwa S; Iravani MM; Zeng BY; Cooper JD; Rose S; Jenner P
    J Neurochem; 2009 Apr; 109(1):52-9. PubMed ID: 19187437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine D2 receptor knockout mice develop features of Parkinson disease.
    Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK
    Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
    Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
    Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of Dengzhan Xixin on blood-brain barrier permeability and metabolites after cerebral ischemia-reperfusion injuries].
    Liu H; Liao W; Wei L; Lei H
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(2):208-11. PubMed ID: 19385188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parkinson's disease and cancer: insights for pathogenesis from epidemiology .
    D'Amelio M; Ragonese P; Sconzo G; Aridon P; Savettieri G
    Ann N Y Acad Sci; 2009 Feb; 1155():324-34. PubMed ID: 19250224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
    Calabresi P; Mercuri NB; Di Filippo M
    Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
    [No Abstract]   [Full Text] [Related]  

  • 51. Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI.
    Durukan A; Marinkovic I; Strbian D; Pitkonen M; Pedrono E; Soinne L; Abo-Ramadan U; Tatlisumak T
    Brain Res; 2009 Jul; 1280():158-65. PubMed ID: 19450568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Olfactory-induced brain activity in Parkinson's disease relates to the expression of event-related potentials: a functional magnetic resonance imaging study.
    Welge-Lüssen A; Wattendorf E; Schwerdtfeger U; Fuhr P; Bilecen D; Hummel T; Westermann B
    Neuroscience; 2009 Aug; 162(2):537-43. PubMed ID: 19401224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
    Kang MJ; Gil SJ; Koh HC
    Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications.
    Sasaki M; Shibata E; Tohyama K; Kudo K; Endoh J; Otsuka K; Sakai A
    Neuroreport; 2008 Nov; 19(17):1649-54. PubMed ID: 18852680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opening of the blood-brain barrier during isoflurane anaesthesia.
    Tétrault S; Chever O; Sik A; Amzica F
    Eur J Neurosci; 2008 Oct; 28(7):1330-41. PubMed ID: 18973560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osmosensitive response of glutamate in the substantia nigra.
    Moráles I; Fuentes A; Gonzalez-Hernandez T; Rodríguez M
    Exp Neurol; 2009 Dec; 220(2):335-40. PubMed ID: 19766632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.